Order Article Reprints
Journal: Pharmaceuticals, 2023
Volume: 16
Number: 239
Article:
Real-World Study on Vedolizumab Serum Concentration, Efficacy, and Safety after the Transition from Intravenous to Subcutaneous Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Experience
Authors:
by
Vlasta Oršić Frič, Vladimir Borzan, Ines Šahinović, Andrej Borzan and Sven Kurbel
Link:
https://www.mdpi.com/1424-8247/16/2/239
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.